Key Barriers in Implementing Guideline-Directed Cholesterol Treatment

Clinical pharmacists discuss how to address key barriers that get in the way of implementing guideline-directed cholesterol treatment.

EP: 1.How Often Do Patients with ASCVD Achieve Target LDL-C?

EP: 2.Gaps Between Guidelines and Clinical Practice Patterns in ASCVD

EP: 3.Comparing the ACC/AHA and ESC/EAS Cholesterol Management Guidelines

Now Viewing

EP: 4.Key Barriers in Implementing Guideline-Directed Cholesterol Treatment

EP: 5.Evaluating Non-Statin Lipid-Lowering Therapies in ASCVD

EP: 6.Clinical Efficacy of Non-Statin Treatment Options in ASCVD

EP: 7.Non-Statin Therapies: Cost Effectiveness and Clinical Evidence Gaps

EP: 8.Persistence and Discontinuation Rates for Non-Statin Therapies in ASCVD

EP: 9.The Role of Pharmacists in Treating Very High-Risk ASCVD

EP: 10.Valuable Metrics and Improving Adherence in Patients With ASCVD

EP: 11.Successful Collaborative Care Strategies for Pharmacists

Related Videos

Related Content

Advertisement

April 3rd 2025

Low HDL-C, Triglyceride Levels in Late Life Independently Associated With Alzheimer Disease and Related Dementias

Luke Halpern, Assistant Editor

March 28th 2025

Very Low LDL-C Achieved With Evolocumab Not Associated With Long-Term Cognitive Impairment

Luke Halpern, Assistant Editor

March 27th 2025

High Low-Density Lipoprotein Cholesterol Associated With Improved Survival in Acutely Decompensated Heart Failure

Luke Halpern, Assistant Editor

March 21st 2025

Elevated Non-HDL Cholesterol a Stronger Indicator of Major Cardiovascular Events Compared With LDL-C

Luke Halpern, Assistant Editor

March 14th 2025

Alcohol Initiation, Cessation Associated With Dose-Dependent Changes in LDL, HDL Cholesterol

Luke Halpern, Assistant Editor

March 7th 2025

Adults With High Ratio of Non-HDL Cholesterol to HDL Cholesterol Have Higher Sarcopenia Risk

Luke Halpern, Assistant Editor

Related Content

Advertisement

April 3rd 2025

Low HDL-C, Triglyceride Levels in Late Life Independently Associated With Alzheimer Disease and Related Dementias

Luke Halpern, Assistant Editor

March 28th 2025

Very Low LDL-C Achieved With Evolocumab Not Associated With Long-Term Cognitive Impairment

Luke Halpern, Assistant Editor

March 27th 2025

High Low-Density Lipoprotein Cholesterol Associated With Improved Survival in Acutely Decompensated Heart Failure

Luke Halpern, Assistant Editor

March 21st 2025

Elevated Non-HDL Cholesterol a Stronger Indicator of Major Cardiovascular Events Compared With LDL-C

Luke Halpern, Assistant Editor

March 14th 2025

Alcohol Initiation, Cessation Associated With Dose-Dependent Changes in LDL, HDL Cholesterol

Luke Halpern, Assistant Editor

March 7th 2025

Adults With High Ratio of Non-HDL Cholesterol to HDL Cholesterol Have Higher Sarcopenia Risk

Luke Halpern, Assistant Editor